|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harvey JM, Clark GM, Osborne CK and Allred
DC: Estrogen receptor status by immunohistochemistry is superior to
the ligand-binding assay for predicting response to adjuvant
endocrine therapy in breast cancer. J Clin Oncol. 17:1474–1481.
1999.PubMed/NCBI
|
|
3
|
Stender JD, Frasor J, Komm B, Chang KC,
Kraus WL and Katzenellenbogen BS: Estrogen-regulated gene networks
in human breast cancer cells: Involvement of E2F1 in the regulation
of cell proliferation. Mol Endocrinol. 21:2112–2123. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Osborne CK: Steroid hormone receptors in
breast cancer management. Breast Cancer Res Treat. 51:227–238.
1998. View Article : Google Scholar
|
|
5
|
Katzenellenbogen BS, Montano MM, Ediger
TR, et al: Estrogen receptors: Selective ligands, partners, and
distinctive pharmacology. Recent Prog Horm Res. 55:163–195.
2000.PubMed/NCBI
|
|
6
|
Frasor J, Danes JM, Komm B, Chang KC,
Lyttle CR and Katzenellenbogen BS: Profiling of estrogen up- and
down-regulated gene expression in human breast cancer cells:
Insights into gene networks and pathways underlying estrogenic
control of proliferation and cell phenotype. Endocrinology.
144:4562–4574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stossi F, Barnett DH, Frasor J, Komm B,
Lyttle CR and Katzenellenbogen BS: Transcriptional profiling of
estrogen-regulated gene expression via estrogen receptor (ER) alpha
or ERbeta in human osteosarcoma cells: Distinct and common target
genes for these receptors. Endocrinology. 145:3473–3486. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pauli A, Rinn JL and Schier AF: Non-coding
RNAs as regulators of embryogenesis. Nat Rev Genet. 12:136–149.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartolomei MS, Zemel S and Tilghman SM:
Parental imprinting of the mouse H19 gene. Nature. 351:153–155.
1991. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ariel I, de Groot N and Hochberg A:
Imprinted H19 gene expression in embryogenesis and human cancer:
The oncofetal connection. Am J Med Genet. 91:46–50. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Glaser T, Housman D, Lewis WH, Gerhard D
and Jones C: A fine-structure deletion map of human chromosome 11p:
Analysis of J1 series hybrids. Somat Cell Mol Genet. 15:477–501.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Long non-coding RNA H19 increases bladder cancer metastasis by
associating with EZH2 and inhibiting E-cadherin expression. Cancer
Lett. 333:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Adriaenssens E, Dumont L, Lottin S, Bolle
D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J and Curgy
JJ: H19 overexpression in breast adenocarcinoma stromal cells is
associated with tumor values and steroid receptor status but
independent of p53 and Ki-67 expression. Am J Pathol.
153:1597–1607. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lottin S, Adriaenssens E, Dupressoir T,
Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ:
Overexpression of an ectopic H19 gene enhances the tumorigenic
properties of breast cancer cells. Carcinogenesis. 23:1885–1895.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Berteaux N, Lottin S, Monté D, Pinte S,
Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and
Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer
cell proliferation through positive control by E2F1. J Biol Chem.
280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adriaenssens E, Lottin S, Dugimont T,
Fauquette W, Coll J, Dupouy JP, Boilly B and Curgy JJ: Steroid
hormones modulate H19 gene expression in both mammary gland and
uterus. Oncogene. 18:4460–4473. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsang WP and Kwok TT: Riboregulator H19
induction of MDR1-associated drug resistance in human
hepatocellular carcinoma cells. Oncogene. 26:4877–4881. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tan C, Cai LQ, Wu W, Qiao Y,
Imperato-McGinley J, Chen GQ and Zhu YS: NSC606985, a novel
camptothecin analog, induces apoptosis and growth arrest in
prostate tumor cells. Cancer Chemother Pharmacol. 63:303–312. 2009.
View Article : Google Scholar
|
|
24
|
Brannan CI, Dees EC, Ingram RS and
Tilghman SM: The product of the H19 gene may function as an RNA.
Mol Cell Biol. 10:28–36. 1990.PubMed/NCBI
|
|
25
|
Gabory A, Jammes H and Dandolo L: The H19
locus: Role of an imprinted non-coding RNA in growth and
development. BioEssays. 32:473–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hao Y, Crenshaw T, Moulton T, Newcomb E
and Tycko B: Tumour-suppressor activity of H19 RNA. Nature.
365:764–767. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barsyte-Lovejoy D, Lau SK, Boutros PC,
Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ: The c-Myc
oncogene directly induces the H19 noncoding RNA by allele-specific
binding to potentiate tumorigenesis. Cancer Res. 66:5330–5337.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Doucrasy S, Coll J, Barrois M, Joubel A,
Prost S, Dozier C, Stehelin D and Riou G: Expression of the human
fetal bac h19 gene in invasive cancers. Int J Oncol. 2:753–758.
1993.PubMed/NCBI
|
|
29
|
Dugimont T, Curgy JJ, Wernert N, Delobelle
A, Raes MB, Joubel A, Stehelin D and Coll J: The H19 gene is
expressed within both epithelial and stromal components of human
invasive adenocarcinomas. Biol Cell. 85:117–124. 1995. View Article : Google Scholar : PubMed/NCBI
|
